Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Mandatory Vaccination in Europe.

Vaz OM, Ellingson MK, Weiss P, Jenness SM, Bardají A, Bednarczyk RA, Omer SB.

Pediatrics. 2020 Feb;145(2). pii: e20190620. doi: 10.1542/peds.2019-0620. Epub 2020 Jan 13.

2.

Association of cognitive biases with human papillomavirus vaccine hesitancy: a cross-sectional study.

Pomares TD, Buttenheim AM, Amin AB, Joyce CM, Porter RM, Bednarczyk RA, Omer SB.

Hum Vaccin Immunother. 2019 Dec 20:1-6. doi: 10.1080/21645515.2019.1698243. [Epub ahead of print]

PMID:
31859593
3.

Understanding the impact of state vaccination laws on exemption rates.

King AR, Salmon KS, Bednarczyk RA.

Curr Opin Pediatr. 2020 Feb;32(1):160-166. doi: 10.1097/MOP.0000000000000844.

PMID:
31790028
4.

Concomitant Utilization of Pre-Exposure Prophylaxis (PrEP) and Meningococcal Vaccine (MenACWY) Among Gay, Bisexual, and Other Men Who Have Sex with Men in Los Angeles County, California.

Holloway IW, Tan D, Bednarczyk RA, Fenimore VL, Randall L, Lutz CS, Frew PM.

Arch Sex Behav. 2020 Jan;49(1):137-146. doi: 10.1007/s10508-019-01500-4. Epub 2019 Oct 18.

PMID:
31628630
5.

Assessment and Validation of Syndromic Case Definitions for Respiratory Syncytial Virus Infections in Young Infants: A Latent Class Analysis.

Lalani K, Yildirim I, Phadke VK, Bednarczyk RA, Omer SB.

Pediatr Infect Dis J. 2019 Dec;38(12):1177-1182. doi: 10.1097/INF.0000000000002468.

PMID:
31568250
6.

MomsTalkShots: An individually tailored educational application for maternal and infant vaccines.

Salmon DA, Limaye RJ, Dudley MZ, Oloko OK, Church-Balin C, Ellingson MK, Spina CI, Brewer SE, Orenstein WA, Halsey NA, Chamberlain AT, Bednarczyk RA, Malik FA, Frew PM, O'Leary ST, Omer SB.

Vaccine. 2019 Oct 8;37(43):6478-6485. doi: 10.1016/j.vaccine.2019.08.080. Epub 2019 Sep 7.

PMID:
31506192
7.

Human papillomavirus vaccination among diverse college students in the state of Georgia: who receives recommendation, who initiates and what are the reasons?

Vu M, Bednarczyk RA, Escoffery C, Getachew B, Berg CJ.

Health Educ Res. 2019 Aug 1;34(4):415-434. doi: 10.1093/her/cyz014.

PMID:
31081024
8.

Missed Opportunities for Rotavirus Vaccination.

Sederdahl BK, Orenstein WA, Yi J, Anderson EJ, Bednarczyk RA.

Pediatrics. 2019 May;143(5). pii: e20182498. doi: 10.1542/peds.2018-2498.

PMID:
31023829
9.

A cross-sectional survey of parental attitudes towards Human papillomavirus vaccination exclusion categories in Brazil.

Gattegno MV, Vertamatti MAF, Bednarczyk RA, Evans DP.

BMC Int Health Hum Rights. 2019 Feb 28;19(1):6. doi: 10.1186/s12914-019-0195-5.

10.

Vaccination perspectives among adolescents and their desired role in the decision-making process.

Herman R, McNutt LA, Mehta M, Salmon DA, Bednarczyk RA, Shaw J.

Hum Vaccin Immunother. 2019;15(7-8):1752-1759. doi: 10.1080/21645515.2019.1571891. Epub 2019 Mar 14.

PMID:
30735440
11.

Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell Lymphoma.

Chang A, Payne JB, Allen PB, Koff JL, Ahmed R, Flowers CR, Bednarczyk RA.

Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):239-243. doi: 10.1016/j.clml.2018.12.018. Epub 2019 Jan 2.

PMID:
30686773
12.

Addressing HPV vaccine myths: practical information for healthcare providers.

Bednarczyk RA.

Hum Vaccin Immunother. 2019;15(7-8):1628-1638. doi: 10.1080/21645515.2019.1565267. Epub 2019 Feb 20.

13.

Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.

Bednarczyk RA, Ellingson MK, Omer SB.

J Infect Dis. 2019 Jul 31;220(5):730-734. doi: 10.1093/infdis/jiy682.

PMID:
30657920
14.

A multilevel analysis of factors influencing the inaccuracy of parental reports of adolescent HPV vaccination status.

Vu M, Luu M, Haardörfer R, Berg CJ, Escoffery C, Bednarczyk RA.

Vaccine. 2019 Feb 4;37(6):869-876. doi: 10.1016/j.vaccine.2018.12.032. Epub 2019 Jan 6.

15.

Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015.

Pham MA, Bednarczyk RA, Becker ER, Orenstein WA, Omer SB.

Vaccine. 2019 Feb 4;37(6):882-888. doi: 10.1016/j.vaccine.2018.12.034. Epub 2019 Jan 4.

PMID:
30616954
16.

Current landscape of nonmedical vaccination exemptions in the United States: impact of policy changes.

Bednarczyk RA, King AR, Lahijani A, Omer SB.

Expert Rev Vaccines. 2019 Feb;18(2):175-190. doi: 10.1080/14760584.2019.1562344. Epub 2019 Jan 4. Review.

17.

Human Papillomavirus Vaccination in Georgia: Evaluating the Georgia HPV Work Group.

King AR, Moon T, Agnew G, Bednarczyk RA.

J Community Health. 2019 Jun;44(3):428-435. doi: 10.1007/s10900-018-00598-2.

PMID:
30542970
18.

Development of a US trust measure to assess and monitor parental confidence in the vaccine system.

Frew PM, Murden R, Mehta CC, Chamberlain AT, Hinman AR, Nowak G, Mendel J, Aikin A, Randall LA, Hargreaves AL, Omer SB, Orenstein WA, Bednarczyk RA.

Vaccine. 2019 Jan 7;37(2):325-332. doi: 10.1016/j.vaccine.2018.09.043. Epub 2018 Nov 30.

19.

Development of a measure to assess vaccine confidence among men who have sex with men.

Frew PM, Holloway IW, Goldbeck C, Tan D, Wu E, Jauregui J, Fenimore VL, Randall LA, Lutz CS, Mendel J, Aikin AL, Nowak GJ, Bednarczyk RA.

Expert Rev Vaccines. 2018 Nov;17(11):1053-1061. doi: 10.1080/14760584.2018.1541405. Epub 2018 Nov 15.

PMID:
30433837
20.

HPV Vaccine-Related Research, Promotion and Coordination in the State of Georgia: A Systematic Review.

Dennison C, King AR, Rutledge H, Bednarczyk RA.

J Community Health. 2019 Apr;44(2):313-321. doi: 10.1007/s10900-018-0589-7.

PMID:
30374822
21.

Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting.

Ibrahim R, Ali SA, Kazi AM, Rizvi A, Guterman LB, Bednarczyk RA, Kim E, Park S, Paulos S, Jeyachandran A, Patel D, Gorantla Y, Wong E, Rajam G, Schiffer J, Omer SB.

Vaccine. 2018 Nov 12;36(46):7048-7053. doi: 10.1016/j.vaccine.2018.09.045. Epub 2018 Oct 5.

22.

Practice-, Provider-, and Patient-level interventions to improve preventive care: Development of the P3 Model.

Bednarczyk RA, Chamberlain A, Mathewson K, Salmon DA, Omer SB.

Prev Med Rep. 2018 Jun 18;11:131-138. doi: 10.1016/j.pmedr.2018.06.009. eCollection 2018 Sep.

23.

Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.

Landis K, Bednarczyk RA, Gaydos LM.

Vaccine. 2018 Jun 7;36(24):3498-3504. doi: 10.1016/j.vaccine.2018.04.075. Epub 2018 May 8.

24.

Examining the "why" of vaccine hesitancy.

Bednarczyk RA.

Health Psychol. 2018 Apr;37(4):316-317. doi: 10.1037/hea0000596.

25.

First nations people's perspectives on barriers and supports for enhancing HPV vaccination: Foundations for sustainable, community-driven strategies.

Henderson RI, Shea-Budgell M, Healy C, Letendre A, Bill L, Healy B, Bednarczyk RA, Mrklas K, Barnabe C, Guichon J, Bedingfield N, MacDonald S, Colquhoun A, Glaze S, Nash T, Bell C, Kellner J, Richardson R, Dixon T, Starlight J, Runner G, Nelson G.

Gynecol Oncol. 2018 Apr;149(1):93-100. doi: 10.1016/j.ygyno.2017.12.024.

26.

Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial.

Porter RM, Amin AB, Bednarczyk RA, Omer SB.

Vaccine. 2018 Apr 25;36(18):2494-2500. doi: 10.1016/j.vaccine.2018.01.040. Epub 2018 Mar 26.

27.

Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol.

Mrklas KJ, MacDonald S, Shea-Budgell MA, Bedingfield N, Ganshorn H, Glaze S, Bill L, Healy B, Healy C, Guichon J, Colquhoun A, Bell C, Richardson R, Henderson R, Kellner J, Barnabe C, Bednarczyk RA, Letendre A, Nelson GS.

Syst Rev. 2018 Mar 2;7(1):40. doi: 10.1186/s13643-018-0692-y. Review.

28.

Trends in Kindergarten Rates of Vaccine Exemption and State-Level Policy, 2011-2016.

Omer SB, Porter RM, Allen K, Salmon DA, Bednarczyk RA.

Open Forum Infect Dis. 2017 Nov 15;5(2):ofx244. doi: 10.1093/ofid/ofx244. eCollection 2018 Feb.

29.

Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.

Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ.

Vaccine. 2018 Feb 1;36(6):818-826. doi: 10.1016/j.vaccine.2017.12.075. Epub 2018 Jan 6.

PMID:
29317117
30.

Exemptions From Mandatory Immunization After Legally Mandated Parental Counseling.

Omer SB, Allen K, Chang DH, Guterman LB, Bednarczyk RA, Jordan A, Buttenheim A, Jones M, Hannan C, deHart MP, Salmon DA.

Pediatrics. 2018 Jan;141(1). pii: e20172364. doi: 10.1542/peds.2017-2364.

31.

Association of moral values with vaccine hesitancy.

Amin AB, Bednarczyk RA, Ray CE, Melchiori KJ, Graham J, Huntsinger JR, Omer SB.

Nat Hum Behav. 2017 Dec;1(12):873-880. doi: 10.1038/s41562-017-0256-5. Epub 2017 Dec 4.

PMID:
31024188
32.

Missed opportunities for catch-up human papillomavirus vaccination among university undergraduates: Identifying health decision-making behaviors and uptake barriers.

Ragan KR, Bednarczyk RA, Butler SM, Omer SB.

Vaccine. 2018 Jan 4;36(2):331-341. doi: 10.1016/j.vaccine.2017.07.041. Epub 2017 Jul 26.

PMID:
28755837
33.

The importance of immunization in cancer prevention, treatment, and survivorship.

Ward EM, Flowers CR, Gansler T, Omer SB, Bednarczyk RA.

CA Cancer J Clin. 2017 Sep;67(5):398-410. doi: 10.3322/caac.21407. Epub 2017 Jul 28. Review.

34.

Moving beyond sex: Assessing the impact of gender identity on human papillomavirus vaccine recommendations and uptake among a national sample of rural-residing LGBT young adults.

Bednarczyk RA, Whitehead JL, Stephenson R.

Papillomavirus Res. 2017 Jun;3:121-125. doi: 10.1016/j.pvr.2017.04.002. Epub 2017 Apr 13.

35.

Missed Opportunities for Hepatitis A Vaccination, National Immunization Survey-Child, 2013.

Casillas SM, Bednarczyk RA.

J Pediatr. 2017 Aug;187:265-271.e1. doi: 10.1016/j.jpeds.2017.04.001. Epub 2017 May 5.

PMID:
28483064
36.

The Church, the State, and Vaccine Policy.

Bednarczyk RA, Tate T, Opel DJ, Omer SB.

Am J Bioeth. 2017 Apr;17(4):50-52. doi: 10.1080/15265161.2017.1284932. No abstract available.

37.

Factors influencing HPV vaccine delivery by healthcare professionals at public health posts in São Paulo, Brazil.

Figueroa-Downing D, Baggio ML, Baker ML, Dias De Oliveira Chiang E, Villa LL, Eluf Neto J, Evans DP, Bednarczyk RA.

Int J Gynaecol Obstet. 2017 Jan;136(1):33-39. doi: 10.1002/ijgo.12004. Epub 2016 Nov 11.

PMID:
28099706
38.

Estimating Pertussis Susceptibility Among 0-23-Month-Old Children in the United States: Using National Immunization Survey (NIS) 2013.

Childs L, Bednarczyk RA.

Pediatr Infect Dis J. 2017 Aug;36(8):705-711. doi: 10.1097/INF.0000000000001537.

PMID:
28060041
39.

ReadyVax: A new mobile vaccine information app.

Bednarczyk RA, Frew PM, Salmon DA, Whitney E, Omer SB.

Hum Vaccin Immunother. 2017 May 4;13(5):1149-1154. doi: 10.1080/21645515.2016.1263779. Epub 2017 Jan 6.

40.

Trends in Personal Belief Exemption Rates Among Alternative Private Schools: Waldorf, Montessori, and Holistic Kindergartens in California, 2000-2014.

Brennan JM, Bednarczyk RA, Richards JL, Allen KE, Warraich GJ, Omer SB.

Am J Public Health. 2017 Jan;107(1):108-112. Epub 2016 Nov 17.

41.

Epidemiology of Pertussis Among Young Pakistani Infants: A Community-Based Prospective Surveillance Study.

Omer SB, Kazi AM, Bednarczyk RA, Allen KE, Quinn CP, Aziz F, Sial K, Phadke VK, Tondella ML, Williams MM, Orenstein WA, Ali SA.

Clin Infect Dis. 2016 Dec 1;63(suppl 4):S148-S153.

42.

Knowledge, attitudes, and practices of healthcare providers in the country of Georgia regarding influenza vaccinations for pregnant women.

Dvalishvili M, Mesxishvili D, Butsashvili M, Kamkamidze G, McFarland D, Bednarczyk RA.

Vaccine. 2016 Nov 21;34(48):5907-5911. doi: 10.1016/j.vaccine.2016.10.033. Epub 2016 Oct 20.

PMID:
27773474
43.

Comparative analysis of the Parent Attitudes about Childhood Vaccines (PACV) short scale and the five categories of vaccine acceptance identified by Gust et al.

Oladejo O, Allen K, Amin A, Frew PM, Bednarczyk RA, Omer SB.

Vaccine. 2016 Sep 22;34(41):4964-4968. doi: 10.1016/j.vaccine.2016.08.046. Epub 2016 Aug 23.

PMID:
27566902
44.

Estimating the Number of Measles-Susceptible Children and Adolescents in the United States Using Data From the National Immunization Survey-Teen (NIS-Teen).

Bednarczyk RA, Orenstein WA, Omer SB.

Am J Epidemiol. 2016 Jul 15;184(2):148-56. doi: 10.1093/aje/kwv320. Epub 2016 Jun 23.

PMID:
27338281
45.

Assessment of the role of international travel and unauthorized immigration on measles importation to the United States.

Bednarczyk RA, Rebolledo PA, Omer SB.

J Travel Med. 2016 Mar 30;23(3). pii: taw019. doi: 10.1093/jtm/taw019. Print 2016 Mar.

PMID:
27029908
46.

Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.

Phadke VK, Bednarczyk RA, Salmon DA, Omer SB.

JAMA. 2016 Mar 15;315(11):1149-58. doi: 10.1001/jama.2016.1353. Review. Erratum in: JAMA. 2016 May 17;315(19):2125. JAMA. 2016 May 17;315 (19):2125.

47.

Factors Associated with Time to Appropriate Treatment in Pertussis Cases in Georgia, 2009 to 2013.

Goodenough D, Thomas E, Tuttle J, Bednarczyk RA.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3051-6. doi: 10.1128/AAC.03067-15. Print 2016 May.

48.

HPV vaccination coverage of teen girls: the influence of health care providers.

Smith PJ, Stokley S, Bednarczyk RA, Orenstein WA, Omer SB.

Vaccine. 2016 Mar 18;34(13):1604-1610. doi: 10.1016/j.vaccine.2016.01.061. Epub 2016 Feb 5.

PMID:
26854907
49.

White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.

Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, Daley MF.

Vaccine. 2016 Feb 15;34 Suppl 1:A1-A29. doi: 10.1016/j.vaccine.2015.10.082.

PMID:
26830300
50.

Reply.

Bednarczyk RA, Figueroa-Downing D, Ault K.

Am J Obstet Gynecol. 2016 May;214(5):667-8. doi: 10.1016/j.ajog.2015.12.059. Epub 2016 Jan 6. No abstract available.

PMID:
26767793

Supplemental Content

Loading ...
Support Center